Ascendis Pharma A/S (Ascendis Pharma A/S) Accumulated other comprehensive income (loss) : $-267.4 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Ascendis Pharma A/S's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was $-267.4 Mil.

Ascendis Pharma A/S's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 ($-86.6 Mil) to Dec. 2023 ($-167.3 Mil) and declined from Dec. 2023 ($-167.3 Mil) to Mar. 2024 ($-267.4 Mil).

Ascendis Pharma A/S's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($989.8 Mil) to Dec. 2022 ($270.8 Mil) and declined from Dec. 2022 ($270.8 Mil) to Dec. 2023 ($-167.3 Mil).

Ascendis Pharma A/S Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Ascendis Pharma A/S's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Accumulated other comprehensive income (loss) Chart

Ascendis Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

656.30

1,011.55

989.82

270.84

-167.34

Ascendis Pharma A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															170.77	61.91	-86.63	-167.34	-267.39

Ascendis Pharma A/S Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Ascendis Pharma A/S Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.